CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Key facts
- Where
- Waltham, United StatesSee the site
Where in United States
- CorEvitas, LLCWaltham, United StatesContact: Jeffrey GreenbergTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- CorEvitas
- Trial code
- NCT05745389
- Record updated
- 9 February 2026
- Original description
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.Read full original descriptionShow less
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Inclusion: A subject must meet all the following criteria to participate in the registry:; Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner; Is at least 18 years of age or older; Is willing to provide Personal Information; Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment.
Exclusion: Any of the following would exclude the subject from participating in the registry:; Is participating or planning to participate in a double-blind randomized trial for an AA drug. Note:; Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.